Advanced Search

Technical Analysis for OPT - Opthea Limited

Grade Last Price % Change Price Change
F 9.98 3.31% 0.32
OPT closed up 3.31 percent on Monday, April 12, 2021, on 2 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical OPT trend table...
Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Fell Below 20 DMA Bearish 3.31%
Multiple of Ten Bearish Other 3.31%
Crossed Above 20 DMA Bullish 2.04%
Multiple of Ten Bearish Other 2.04%
Gapped Up Strength 2.04%
Fell Below 20 DMA Bearish 7.78%
Narrow Range Bar Range Contraction 7.78%
Older End-of-Day Signals for OPT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High 5 days ago
Rose Above 10 DMA 5 days ago
20 DMA Resistance 5 days ago
Up 5% 5 days ago
Up 3% 5 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Opthea Limited operates as a biotechnology company. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.
Classification
Sector: Other
Industry: Other
Keywords: Medicine Biotechnology Eye Organ Systems Diabetes Healthcare Providers Ophthalmology Diabetic Retinopathy Macular Edema Transplantation Blindness Eye Disease Diabetic Macular Edema Cornea Angiology Dry Eye Disease

Is OPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 6 Opthea chief financial officer resigns
Apr 6 Opthea Company Secretary Resignation
Mar 31 Opthea gains 6% after receiving FDA waiver for OPT-302 study in wet AMD
Mar 31 Opthea Receives FDA Waiver for Pediatric Study Plan for OPT-302 in Wet AMD
Mar 15 Opthea Treats First Patient in Phase 3 Pivotal Trials of OPT-302 in Wet AMD
Mar 10 Opthea to Present at the Oppenheimer 31st Annual Healthcare Conference
Mar 2 Here's Why We're Not Too Worried About Opthea's (ASX:OPT) Cash Burn Situation
Feb 24 Opthea Finalizes Study Designs and Start-up Activities for Phase 3 Pivotal Clinical Trials of OPT-302 in Wet AMD
Feb 17 Opthea to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Dec 29 The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
See more OPT news...

Indicators

Indicator Value
52 Week High 21.36
52 Week Low 0.0
Average Volume 14,812
200-Day Moving Average 0.00
50-Day Moving Average 10.20
20-Day Moving Average 9.74
10-Day Moving Average 9.58
Average True Range 0.54
ADX 10.39
+DI 27.73
-DI 25.02
Chandelier Exit (Long, 3 ATRs ) 9.17
Chandelier Exit (Short, 3 ATRs ) 10.53
Upper Bollinger Band 10.52
Lower Bollinger Band 8.95
Percent B (%b) 0.66
BandWidth 16.06
MACD Line -0.12
MACD Signal Line -0.20
MACD Histogram 0.084
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.98
Resistance 3 (R3) 9.98 9.98 9.98
Resistance 2 (R2) 9.98 9.98 9.98 9.98
Resistance 1 (R1) 9.98 9.98 9.98 9.98 9.98
Pivot Point 9.98 9.98 9.98 9.98 9.98
Support 1 (S1) 9.98 9.98 9.98 9.98 9.98
Support 2 (S2) 9.98 9.98 9.98 9.98
Support 3 (S3) 9.98 9.98 9.98
Support 4 (S4) 9.98